Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03273491 · ClinicalTrials.gov registry record · NA
Self-Weighing: an Ecological Momentary Assessment
A NA study, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03273491: Completed NA study, sponsored by University of Delaware.
NCT03273491 is a NA study that has completed, run by University of Delaware. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03273491, a NA study, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The primary objective of this study is to experimentally test the momentary and more distal psychological effects of daily self weighing as compared to an active control group.
Primary Outcome
1. Daily self-weighing will result in significantly greater reactivity than daily-temperature-taking 2. There will be no significance in mood ratings between daily self-weighing and daily temperature-taking groups for EMA recordings later in the day. 3. The daily self-weighing group will report significantly more weight control behaviors at the end of the day as compared to the daily temperature-taking group.
Interventions
- BEHAVIORAL daily self-weighing
- BEHAVIORAL daily temperature-taking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2017-12-29 |
| Phase | NA |
What the finished NCT03273491 record still lists
NCT03273491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which daily self-weighing is the first listed.
NCT03273491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03273491 about?
NCT03273491 is a clinical study titled "Self-Weighing: an Ecological Momentary Assessment". The primary objective of this study is to experimentally test the momentary and more distal psychological effects of daily self weighing as compared to an active control group.
What is the current status of trial NCT03273491?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2017-06-01. Estimated completion is 2017-12-29.
What interventions are being tested in trial NCT03273491?
The interventions under investigation include: daily self-weighing (BEHAVIORAL), daily temperature-taking (BEHAVIORAL).
Who is sponsoring clinical trial NCT03273491?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03273491's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI